Select a community
Fibromyalgia And Chronic Fatigue Syndrome
Find out more about the PatientsLikeMe
Fibromyalgia And Chronic Fatigue Syndrome Community
Home > Community Treatment Reports > Levothyroxine Treatment Report
What is Levothyroxine?

Levothyroxine is a synthetic form of the human hormone thyroxine. The drug is used to treat hypothyroidism (underactive thyroid), which can lead to weight gain, depression, and pain.

Side Effects

Side effects as an overall problem

Severe
2
Moderate
4
Mild
5
None
36

Most commonly reported side effects

Fatigue
3
Nausea
1
Muscle and joint pain
1
Weight gain
1
Night sweats
1
Problems concentrating
1
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Levothyroxine. See all 47 dosages ►

  daily 25 mcg (0.025 mg) daily 25 mcg (0.025 mg) daily 50 mcg (0.05 mg) every other day 75 mcg (0.075 mg) every other day 88 mcg (0.088 mg) every other day 50 mcg (0.05 mg) daily 150 mcg (0.15 mg) every other day 75 mcg (0.075 mg) daily 88 mcg (0.088 mg) daily 0.1 mg daily 100 mcg (0.1 mg) daily 2 x 50 mcg (0.05 mg) daily 112 mcg (0.112 mg) daily 125 mcg (0.125 mg) daily 0.137 mcg daily 137 mcg (0.137 mg) daily 150 mcg (0.15 mg) daily 2 x 75 mcg (0.075 mg) daily 1.5 x 112 mcg (0.112 mg) daily 175 mcg (0.175 mg) daily 200 mcg (0.2 mg) daily 2 x 112 mcg (0.112 mg) daily 3 x 75 mcg (0.075 mg) daily 0.25 mg daily 2 x 125 mcg (0.125 mg) daily 300 mcg (0.3 mg) daily 3 x 100 mcg (0.1 mg) daily 2 x 200 mcg (0.2 mg) daily 1 mg daily 1 other daily 1.25 mg daily 5 mcg daily 100 x 100 mcg (0.1 mg) daily 10 mg daily 25 mcg daily 50 mcg daily 50 mg daily 75 mcg daily 75 mg daily 100 mcg daily 100 mg daily 125 mcg daily 188 mcg daily 225 mg daily 250 mcg daily 262 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 30 Number of Patients: 30 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 79 Number of Patients: 79 1 Number of Patients: 1 68 Number of Patients: 68 24 Number of Patients: 24 1 Number of Patients: 1 49 Number of Patients: 49 2 Number of Patients: 2 18 Number of Patients: 18 33 Number of Patients: 33 1 Number of Patients: 1 8 Number of Patients: 8 36 Number of Patients: 36 2 Number of Patients: 2 1 Number of Patients: 1 8 Number of Patients: 8 17 Number of Patients: 17 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Levothyroxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
7   Doctor's advice: 35%
Other
7   Other: 35%
Did not seem to work
6   Did not seem to work: 30%
Personal research
3   Personal research: 15%
Side effects too severe
1   Side effects too severe: 5%
Not indicated
1   Not indicated: 5%
Expense
1   Expense: 5%

See all 20 patients who’ve stopped taking Levothyroxine

Duration See details about how long patients take this treatment ▼

Currently Taking Levothyroxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Levothyroxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
40 85%
Usually
7 15%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 2%
Somewhat
5 11%
A little
10 21%
Not at all
31 66%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 2%
$25-49
2 4%
< $25
35 74%

See more information, including instructions, precautions, side effects, and interactions.

Report created on September 09, 2010.